PharmiWeb.com - Global Pharma News & Resources
04-May-2022

Worldwide Generic Oncology Sterile Injectable Industry to 2027 - Featuring Baxter International, Biocon and Eli Lilly & Company Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Generic Oncology Sterile Injectable Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.


The global generic oncology sterile injectable market is expected to grow at a CAGR of around 11.3% during 2021-2027.

This report on global generic oncology sterile injectable market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape.

The report presents a clear picture of the global generic oncology sterile injectable market by segmenting the market based on size, product type, disease indication, distribution channel, and region. Also, detailed profiles of companies operating in the generic oncology sterile injectable market are provided in this report.

Historical & Forecast Period

  • Base Year: 2020
  • Historical Period: 2016-2019
  • Forecast Period: 2021-2027

Market Dynamics

Drivers

  • Increasing Launches of Drugs
  • Rising Prevalence of Cancer

Challenges

  • Stringent Rules and Regulations for Manufacturing
  • High Operational Costs

Market by Product Type

  • Chemotherapy
  • Alkylating Agents
  • Antimetabolites
  • Plant Alkaloids
  • Antitumor Antibiotics
  • Others
  • Monoclonal Antibodies
  • Cytokines
  • Peptide Hormones

Market by Disease Indication

  • Ovarian Cancer
  • Breast Cancer
  • Lung Cancer
  • Pancreatic Cancer
  • Others

Market by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Market by Region

  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Rest of Asia Pacific
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • Turkey
  • Iran
  • United Arab Emirates
  • Rest of Middle East & Africa

Companies Mentioned

  • Baxter International Inc.
  • Biocon Ltd.
  • Eli Lilly & Company
  • Hikma Pharmaceuticals PLC
  • Mylan N.V.
  • Pfizer Inc.
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/veo16w.


Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 04-May-2022